Cushing's syndrome due to antiretroviral-budesonide interaction

Annals of Pharmacotherapy

Volumn 45, Issue 6, 2011, Pages 823-

  Frankel, Jonathan K ^a   Packer, Clifford D ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ATAZANAVIR; ATENOLOL; ATROPINE PLUS DIPHENOXYLATE; BUDESONIDE; CALCITRIOL; COLECALCIFEROL; FONDAPARINUX; FUROSEMIDE; HYDRALAZINE; LAMIVUDINE; LEVOTHYROXINE; LISINOPRIL; LOPERAMIDE; NEVIRAPINE; RANITIDINE; RITONAVIR; TRAZODONE; VARDENAFIL;

AGED; BEDTIME DOSAGE; CASE REPORT; CHRONIC DIARRHEA; COLONOSCOPY; CUSHING SYNDROME; DRUG INTERACTION; EDEMA; HUMAN; HYPERTENSION; LEG SWELLING; LETTER; LYMPHOCYTIC COLITIS; MALE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; SIDE EFFECT; WEIGHT GAIN;

AGED; BUDESONIDE; CUSHING SYNDROME; CYTOCHROME P-450 CYP3A; DRUG INTERACTIONS; GLUCOCORTICOIDS; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; OLIGOPEPTIDES; PYRIDINES; RITONAVIR;

EID: 79958818435     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1P731     Document Type: Letter

References (7)

1. Sagir A, Schmitt M, Dilger K, Haussinger D. Inhibition of cytochrome P450 3A: relevant drug interactions in gastroenterology. Digestion 2003; 68:41-8.
2. Zhang Y, Benet LZ. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin Pharmacokinet 2001;40:159-68.
3. Foisy MM, Yakiwchuk EMK, Chiu L, Singh AE. Adrenal suppression and Cushing's syndrome secondary to an interaction between ritonavir and fluticasone: a review of the literature. HIV Medicine 2008;9:389-96.
4. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
5. Horn JR, Hansten PD, Chan L-N. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007;41:674-80. DOI 10.1345/aph.1H423
6. De Wachter E, Malfroot A, De Schutter I, Vanbesien J, De Schepper J. Inhaled budesonide induced Cushing's syndrome in cystic fibrosis patients, due to drug inhibition of cytochrome P450. J Cyst Fibros 2003;2:72-5.
7. Kedem E, Shahar E, Hassoun G, Pollock S. Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. J Asthma 2010;47:830-1.